USD 32,998.89 million
Report ID:
SQMIG35A2598 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
104
|Figures:
72
Global Hospital-Acquired Infection Control Market size was valued at USD 32,998.89 million in 2022 and is poised to grow from USD 34,007.11 million in 2023 to USD 44,062.37 million by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).
The market for Hospital Acquired Infections (HAIs) is being propelled by several key factors. Heightened awareness surrounding the significance of curbing cross infections, coupled with the prevalence of infectious diseases within healthcare facilities, serves as a primary driver. Moreover, supportive government initiatives aimed at promoting infection control practices contribute significantly to market growth.
The establishment of rigorous infection prevention standards and protocols, implemented at various levels from hospitals to regional and national scales, plays a pivotal role in fostering a culture of safety and hygiene. Additionally, the increasing adoption of monitoring solutions further amplifies this trajectory, facilitating proactive measures to prevent and manage HAIs effectively.
Global Market Size
USD 32,998.89 million
Largest Segment
services
Fastest Growth
Growth Rate
7.3% CAGR
To get more reports on the above market click here to Buy The Report
The global hospital-acquired infection control market is segmented into four major segments i.e. by product, infection type, end-user and region. Based on product & service the market is segmented as, sterilization, sterilization product, heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables & accessories, cleaning & disinfection products, disinfectants, disinfectors equipment, others, protective barriers, endoscope reprocessing products. Based on infection type the market is segmented as, hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (uti), others. Based on end user the market is segmented as, hospitals & clinics, ambulatory surgical centers, others. Based on region the market is segmented as, North America, Europe, Asia-Pacific, MEA, and Latin America.
Analysis by Type
The consumables segment has emerged as the dominant force within the market, claiming a significant revenue share of 47.0%. This commanding presence is primarily attributed to the substantial utilization of consumables in hospitals and ambulatory centers, reflecting their indispensability in healthcare settings. Moreover, the market's robust investment in Research and Development (R&D) initiatives by key players further bolsters the consumables segment.
The services segment is poised to exhibit a notable CAGR of 5.2% throughout the forecast period, signifying robust growth prospects. This category encompasses a spectrum of offerings, including disinfection-as-a-service, the formulation and execution of infection control programs, and the development of compliance-monitoring software, among others.
Analysis by End-User
The hospitals and Intensive Care Units (ICUs) segment emerged as the market frontrunner, commanding a significant revenue share of 46.0% in 2020. Studies, such as the one conducted by the Kerman University of Medical Sciences in Iran, shed light on the impact of the COVID-19 pandemic on nosocomial (HAIs) infections within healthcare settings. Surprisingly, despite lower patient admissions to ICUs compared to other wards, the incidence of HAIs was notably higher in these critical care units.
The ambulatory surgical and diagnostic centers segment is poised to experience a rapid CAGR of 5.2% in the forecast period, marking significant growth prospects. This surge is expected to be fueled by competitors offering tailored products specifically designed for Ambulatory Surgery Centers (ASCs). Custom-made solutions addressing the unique needs of ASCs are anticipated to drive the adoption of HAIs control products in the forthcoming years.
To get detailed analysis on other segments, Request For Free Sample Report
North America emerged as the dominant force within the market, securing a substantial revenue share exceeding 34.0% in 2022. This commanding presence can be attributed to several key factors shaping the region's healthcare landscape. The region boasts the presence of key industry players actively engaged in combating Hospital Acquired Infections (HAIs) through comprehensive initiatives spanning both public and private sectors.
In the Asia Pacific region, the market is forecasted to experience a notable CAGR of 5.7% in the coming years, signifying robust growth prospects. This upward trajectory is primarily attributed to two key factors shaping the healthcare landscape in the region. There's a rising prevalence of Hospital Acquired Infections (HAIs) within healthcare facilities across various Asian countries.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Increasing Number of Surgical Procedures
Restraints
Concerns Regarding the Safety of Reprocessed Instruments
Request Free Customization of this report to help us to meet your business objectives.
The competitive environment of the global hospital-acquired infection control market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.
Top Player’s Company Profiles
Recent Developments
The STERIS V-PRO® Low-Temperature Sterilization System was introduced in 2023. It uses vaporized hydrogen peroxide (VH2O2) technology to sterilize a variety of medical devices at 40°C, a low temperature. This works well for sterilizing heat-sensitive devices that traditional methods are unable to sanitize.
In September 2023, 3M introduces a new coating called 3M Clean-Coat Surface Protectant, which is intended to stop the spread of illnesses in hospitals. This coating may eradicate up to 99.9% of bacteria and viruses and is intended to be applied to high-touch surfaces like bed rails and doorknobs.
The BD Phoenix Automated Microbiology System, a novel platform for the quick and precise identification and antimicrobial susceptibility testing of microorganisms, is introduced by BD (Becton, Dickinson and Company) in October 2023. The goal of this approach is to assist hospitals diagnose and treat infections more quickly, which can lead to better patient outcomes.
Reintroduction of Ethylene Oxide Sterilization
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global hospital-acquired infection control market analysis reveals a dynamic marketplace with a number of standout trends and difficulties. The escalating prevalence of chronic diseases in both the United States and Canada is driving higher rates of hospitalization, consequently amplifying the demand for effective Hospital-Acquired Infection (HAI) control measures. Over the forecast period, the surge in research and development endeavors within the region is anticipated to play a pivotal role in steering the market. This uptick in R&D activities is primarily attributed to the robust presence of major market players, who are actively investing in innovative solutions to tackle HAIs.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 32,998.89 million |
Market size value in 2031 | USD 44,062.37 million |
Growth Rate | 7.3% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Hospital-Acquired Infection Control Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Hospital-Acquired Infection Control Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Hospital-Acquired Infection Control Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Hospital-Acquired Infection Control Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2598
sales@skyquestt.com
USA +1 351-333-4748